Skip to content
Back to outputs

In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis

Research output: Contribution to journalArticlepeer-review

Standard

In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis. / Rumney, Robin Mark Howard; Tozzi, Gianluca; Kao, Alex; Lanham, Stuart; Kanczler, Janos; Thiagarajan, Lalitha; Dixon, James; Oreffo, Richard.

In: Scientific Reports, Vol. 9, 17745, 28.11.2019.

Research output: Contribution to journalArticlepeer-review

Harvard

Rumney, RMH, Tozzi, G, Kao, A, Lanham, S, Kanczler, J, Thiagarajan, L, Dixon, J & Oreffo, R 2019, 'In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis', Scientific Reports, vol. 9, 17745. https://doi.org/10.1038/s41598-019-53249-4

APA

Rumney, R. M. H., Tozzi, G., Kao, A., Lanham, S., Kanczler, J., Thiagarajan, L., Dixon, J., & Oreffo, R. (2019). In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis. Scientific Reports, 9, [17745]. https://doi.org/10.1038/s41598-019-53249-4

Vancouver

Author

Rumney, Robin Mark Howard ; Tozzi, Gianluca ; Kao, Alex ; Lanham, Stuart ; Kanczler, Janos ; Thiagarajan, Lalitha ; Dixon, James ; Oreffo, Richard. / In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis. In: Scientific Reports. 2019 ; Vol. 9.

Bibtex

@article{8d3e723825164b0b8ce2a881a5434566,
title = "In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis",
abstract = "Deficient bone vasculature is a key component in pathological conditions ranging from developmental skeletal abnormalities to impaired bone repair. Vascularisation is dependent upon vascular endothelial growth factor (VEGF), which drives both angiogenesis and osteogenesis. The aim of this study was to examine the efficacy of blood vessel and bone formation following transfection with VEGF RNA or delivery of recombinant human VEGF165 protein (rhVEGF165) across in vitro and in vivo model systems. To quantify blood vessels within bone, an innovative approach was developed using high-resolution X-ray computed tomography (XCT) to generate quantifiable three-dimensional reconstructions. Application of rhVEGF165 enhanced osteogenesis, as evidenced by increased human osteoblast-like MG-63 cell proliferation in vitro and calvarial bone thickness following in vivo administration. In contrast, transfection with VEGF RNA triggered angiogenic effects by promoting VEGF protein secretion from MG-63VEGF165 cells in vitro, which resulted in significantly increased angiogenesis in the chorioallantoic (CAM) assay in ovo. Furthermore, direct transfection of bone with VEGF RNA in vivo increased intraosseous vascular branching. This study demonstrates the importance of continuous supply as opposed to a single high dose of VEGF on angiogenesis and osteogenesis and, illustrates the potential of XCT in delineating in 3D, blood vessel connectivity in bone. ",
keywords = "RCUK, MRC, MR/K026682/1",
author = "Rumney, {Robin Mark Howard} and Gianluca Tozzi and Alex Kao and Stuart Lanham and Janos Kanczler and Lalitha Thiagarajan and James Dixon and Richard Oreffo",
year = "2019",
month = nov,
day = "28",
doi = "10.1038/s41598-019-53249-4",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

RIS

TY - JOUR

T1 - In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis

AU - Rumney, Robin Mark Howard

AU - Tozzi, Gianluca

AU - Kao, Alex

AU - Lanham, Stuart

AU - Kanczler, Janos

AU - Thiagarajan, Lalitha

AU - Dixon, James

AU - Oreffo, Richard

PY - 2019/11/28

Y1 - 2019/11/28

N2 - Deficient bone vasculature is a key component in pathological conditions ranging from developmental skeletal abnormalities to impaired bone repair. Vascularisation is dependent upon vascular endothelial growth factor (VEGF), which drives both angiogenesis and osteogenesis. The aim of this study was to examine the efficacy of blood vessel and bone formation following transfection with VEGF RNA or delivery of recombinant human VEGF165 protein (rhVEGF165) across in vitro and in vivo model systems. To quantify blood vessels within bone, an innovative approach was developed using high-resolution X-ray computed tomography (XCT) to generate quantifiable three-dimensional reconstructions. Application of rhVEGF165 enhanced osteogenesis, as evidenced by increased human osteoblast-like MG-63 cell proliferation in vitro and calvarial bone thickness following in vivo administration. In contrast, transfection with VEGF RNA triggered angiogenic effects by promoting VEGF protein secretion from MG-63VEGF165 cells in vitro, which resulted in significantly increased angiogenesis in the chorioallantoic (CAM) assay in ovo. Furthermore, direct transfection of bone with VEGF RNA in vivo increased intraosseous vascular branching. This study demonstrates the importance of continuous supply as opposed to a single high dose of VEGF on angiogenesis and osteogenesis and, illustrates the potential of XCT in delineating in 3D, blood vessel connectivity in bone.

AB - Deficient bone vasculature is a key component in pathological conditions ranging from developmental skeletal abnormalities to impaired bone repair. Vascularisation is dependent upon vascular endothelial growth factor (VEGF), which drives both angiogenesis and osteogenesis. The aim of this study was to examine the efficacy of blood vessel and bone formation following transfection with VEGF RNA or delivery of recombinant human VEGF165 protein (rhVEGF165) across in vitro and in vivo model systems. To quantify blood vessels within bone, an innovative approach was developed using high-resolution X-ray computed tomography (XCT) to generate quantifiable three-dimensional reconstructions. Application of rhVEGF165 enhanced osteogenesis, as evidenced by increased human osteoblast-like MG-63 cell proliferation in vitro and calvarial bone thickness following in vivo administration. In contrast, transfection with VEGF RNA triggered angiogenic effects by promoting VEGF protein secretion from MG-63VEGF165 cells in vitro, which resulted in significantly increased angiogenesis in the chorioallantoic (CAM) assay in ovo. Furthermore, direct transfection of bone with VEGF RNA in vivo increased intraosseous vascular branching. This study demonstrates the importance of continuous supply as opposed to a single high dose of VEGF on angiogenesis and osteogenesis and, illustrates the potential of XCT in delineating in 3D, blood vessel connectivity in bone.

KW - RCUK

KW - MRC

KW - MR/K026682/1

U2 - 10.1038/s41598-019-53249-4

DO - 10.1038/s41598-019-53249-4

M3 - Article

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 17745

ER -

ID: 15959352